AAIC 2025 Abstract·28 DecEvaluating the Efficacy and Risks of Early Lecanemab Treatment in APOE4 Humanized Alzheimer's Disease Mouse ModelsExperiments in animalsInterventionsPaper
AAIC 2025 Abstract·26 DecPRECISE‐AD, A Phase 1b, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients with Early Alzheimer's DiseaseInterventionsPaper
AAIC 2025 Abstract·25 DecProtein misfolding‐specific epitope identification for passive and active immunotherapy of neurodegenerative diseasesComputational studyInterventionsPaper